Global Diphtheria, Pertussis, and Tetanus Vaccine Market Research Report 2024(Status and Outlook)
![](/report_cover/11711/global-diphtheria-pertussis-n-tetanus-vaccine-market-research-report-2024status-n-outlook_en.gif)
Report Overview:
Diphtheria, pertussis, and tetanus (DPT) vaccine is administered for three infectious diseases in humans-diphtheria, tetanus, and pertussis. They are administered either in childhood or middle age to produce the acquired immunity against diphtheria, pertussis, and tetanus.
The Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size was estimated at USD 2625.94 million in 2023 and is projected to reach USD 3303.52 million by 2029, exhibiting a CAGR of 3.90% during the forecast period.
This report provides a deep insight into the global Diphtheria, Pertussis, and Tetanus Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Diphtheria, Pertussis, and Tetanus Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Diphtheria, Pertussis, and Tetanus Vaccine market in any manner.
Global Diphtheria, Pertussis, and Tetanus Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Johnson & Johnson
GlaxoSmithKline
Sanofi
Lanzhou Institute of Biological
Merck
Novartis
AstraZeneca
Emergent
Astellas
Market Segmentation (by Type)
DTaP
Td
Tdap
Market Segmentation (by Application)
Hospitals
Clinics
Vaccination Centers
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Diphtheria, Pertussis, and Tetanus Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Diphtheria, pertussis, and tetanus (DPT) vaccine is administered for three infectious diseases in humans-diphtheria, tetanus, and pertussis. They are administered either in childhood or middle age to produce the acquired immunity against diphtheria, pertussis, and tetanus.
The Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size was estimated at USD 2625.94 million in 2023 and is projected to reach USD 3303.52 million by 2029, exhibiting a CAGR of 3.90% during the forecast period.
This report provides a deep insight into the global Diphtheria, Pertussis, and Tetanus Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Diphtheria, Pertussis, and Tetanus Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Diphtheria, Pertussis, and Tetanus Vaccine market in any manner.
Global Diphtheria, Pertussis, and Tetanus Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Johnson & Johnson
GlaxoSmithKline
Sanofi
Lanzhou Institute of Biological
Merck
Novartis
AstraZeneca
Emergent
Astellas
Market Segmentation (by Type)
DTaP
Td
Tdap
Market Segmentation (by Application)
Hospitals
Clinics
Vaccination Centers
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Diphtheria, Pertussis, and Tetanus Vaccine Market
- Overview of the regional outlook of the Diphtheria, Pertussis, and Tetanus Vaccine Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Diphtheria, Pertussis, and Tetanus Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Diphtheria, Pertussis, and Tetanus Vaccine
1.2 Key Market Segments
1.2.1 Diphtheria, Pertussis, and Tetanus Vaccine Segment by Type
1.2.2 Diphtheria, Pertussis, and Tetanus Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 DIPHTHERIA, PERTUSSIS, AND TETANUS VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 DIPHTHERIA, PERTUSSIS, AND TETANUS VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Manufacturers (2019-2024)
3.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.3 Diphtheria, Pertussis, and Tetanus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Diphtheria, Pertussis, and Tetanus Vaccine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Diphtheria, Pertussis, and Tetanus Vaccine Sales Sites, Area Served, Product Type
3.6 Diphtheria, Pertussis, and Tetanus Vaccine Market Competitive Situation and Trends
3.6.1 Diphtheria, Pertussis, and Tetanus Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Diphtheria, Pertussis, and Tetanus Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 DIPHTHERIA, PERTUSSIS, AND TETANUS VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Diphtheria, Pertussis, and Tetanus Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF DIPHTHERIA, PERTUSSIS, AND TETANUS VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 DIPHTHERIA, PERTUSSIS, AND TETANUS VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Type (2019-2024)
6.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size Market Share by Type (2019-2024)
6.4 Global Diphtheria, Pertussis, and Tetanus Vaccine Price by Type (2019-2024)
7 DIPHTHERIA, PERTUSSIS, AND TETANUS VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Sales by Application (2019-2024)
7.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size (M USD) by Application (2019-2024)
7.4 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Growth Rate by Application (2019-2024)
8 DIPHTHERIA, PERTUSSIS, AND TETANUS VACCINE MARKET SEGMENTATION BY REGION
8.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Region
8.1.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Region
8.1.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Johnson and Johnson
9.1.1 Johnson and Johnson Diphtheria, Pertussis, and Tetanus Vaccine Basic Information
9.1.2 Johnson and Johnson Diphtheria, Pertussis, and Tetanus Vaccine Product Overview
9.1.3 Johnson and Johnson Diphtheria, Pertussis, and Tetanus Vaccine Product Market Performance
9.1.4 Johnson and Johnson Business Overview
9.1.5 Johnson and Johnson Diphtheria, Pertussis, and Tetanus Vaccine SWOT Analysis
9.1.6 Johnson and Johnson Recent Developments
9.2 GlaxoSmithKline
9.2.1 GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Basic Information
9.2.2 GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Product Overview
9.2.3 GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Product Market Performance
9.2.4 GlaxoSmithKline Business Overview
9.2.5 GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine SWOT Analysis
9.2.6 GlaxoSmithKline Recent Developments
9.3 Sanofi
9.3.1 Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Basic Information
9.3.2 Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Product Overview
9.3.3 Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Product Market Performance
9.3.4 Sanofi Diphtheria, Pertussis, and Tetanus Vaccine SWOT Analysis
9.3.5 Sanofi Business Overview
9.3.6 Sanofi Recent Developments
9.4 Lanzhou Institute of Biological
9.4.1 Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Basic Information
9.4.2 Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Product Overview
9.4.3 Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Product Market Performance
9.4.4 Lanzhou Institute of Biological Business Overview
9.4.5 Lanzhou Institute of Biological Recent Developments
9.5 Merck
9.5.1 Merck Diphtheria, Pertussis, and Tetanus Vaccine Basic Information
9.5.2 Merck Diphtheria, Pertussis, and Tetanus Vaccine Product Overview
9.5.3 Merck Diphtheria, Pertussis, and Tetanus Vaccine Product Market Performance
9.5.4 Merck Business Overview
9.5.5 Merck Recent Developments
9.6 Novartis
9.6.1 Novartis Diphtheria, Pertussis, and Tetanus Vaccine Basic Information
9.6.2 Novartis Diphtheria, Pertussis, and Tetanus Vaccine Product Overview
9.6.3 Novartis Diphtheria, Pertussis, and Tetanus Vaccine Product Market Performance
9.6.4 Novartis Business Overview
9.6.5 Novartis Recent Developments
9.7 AstraZeneca
9.7.1 AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Basic Information
9.7.2 AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Product Overview
9.7.3 AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Product Market Performance
9.7.4 AstraZeneca Business Overview
9.7.5 AstraZeneca Recent Developments
9.8 Emergent
9.8.1 Emergent Diphtheria, Pertussis, and Tetanus Vaccine Basic Information
9.8.2 Emergent Diphtheria, Pertussis, and Tetanus Vaccine Product Overview
9.8.3 Emergent Diphtheria, Pertussis, and Tetanus Vaccine Product Market Performance
9.8.4 Emergent Business Overview
9.8.5 Emergent Recent Developments
9.9 Astellas
9.9.1 Astellas Diphtheria, Pertussis, and Tetanus Vaccine Basic Information
9.9.2 Astellas Diphtheria, Pertussis, and Tetanus Vaccine Product Overview
9.9.3 Astellas Diphtheria, Pertussis, and Tetanus Vaccine Product Market Performance
9.9.4 Astellas Business Overview
9.9.5 Astellas Recent Developments
10 DIPHTHERIA, PERTUSSIS, AND TETANUS VACCINE MARKET FORECAST BY REGION
10.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size Forecast
10.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Diphtheria, Pertussis, and Tetanus Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Market Size Forecast by Region
10.2.4 South America Diphtheria, Pertussis, and Tetanus Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Diphtheria, Pertussis, and Tetanus Vaccine by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Diphtheria, Pertussis, and Tetanus Vaccine by Type (2025-2030)
11.1.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Diphtheria, Pertussis, and Tetanus Vaccine by Type (2025-2030)
11.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Forecast by Application (2025-2030)
11.2.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales (Kilotons) Forecast by Application
11.2.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Diphtheria, Pertussis, and Tetanus Vaccine
1.2 Key Market Segments
1.2.1 Diphtheria, Pertussis, and Tetanus Vaccine Segment by Type
1.2.2 Diphtheria, Pertussis, and Tetanus Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 DIPHTHERIA, PERTUSSIS, AND TETANUS VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 DIPHTHERIA, PERTUSSIS, AND TETANUS VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Manufacturers (2019-2024)
3.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.3 Diphtheria, Pertussis, and Tetanus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Diphtheria, Pertussis, and Tetanus Vaccine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Diphtheria, Pertussis, and Tetanus Vaccine Sales Sites, Area Served, Product Type
3.6 Diphtheria, Pertussis, and Tetanus Vaccine Market Competitive Situation and Trends
3.6.1 Diphtheria, Pertussis, and Tetanus Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Diphtheria, Pertussis, and Tetanus Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 DIPHTHERIA, PERTUSSIS, AND TETANUS VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Diphtheria, Pertussis, and Tetanus Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF DIPHTHERIA, PERTUSSIS, AND TETANUS VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 DIPHTHERIA, PERTUSSIS, AND TETANUS VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Type (2019-2024)
6.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size Market Share by Type (2019-2024)
6.4 Global Diphtheria, Pertussis, and Tetanus Vaccine Price by Type (2019-2024)
7 DIPHTHERIA, PERTUSSIS, AND TETANUS VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Sales by Application (2019-2024)
7.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size (M USD) by Application (2019-2024)
7.4 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Growth Rate by Application (2019-2024)
8 DIPHTHERIA, PERTUSSIS, AND TETANUS VACCINE MARKET SEGMENTATION BY REGION
8.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Region
8.1.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Region
8.1.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Johnson and Johnson
9.1.1 Johnson and Johnson Diphtheria, Pertussis, and Tetanus Vaccine Basic Information
9.1.2 Johnson and Johnson Diphtheria, Pertussis, and Tetanus Vaccine Product Overview
9.1.3 Johnson and Johnson Diphtheria, Pertussis, and Tetanus Vaccine Product Market Performance
9.1.4 Johnson and Johnson Business Overview
9.1.5 Johnson and Johnson Diphtheria, Pertussis, and Tetanus Vaccine SWOT Analysis
9.1.6 Johnson and Johnson Recent Developments
9.2 GlaxoSmithKline
9.2.1 GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Basic Information
9.2.2 GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Product Overview
9.2.3 GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Product Market Performance
9.2.4 GlaxoSmithKline Business Overview
9.2.5 GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine SWOT Analysis
9.2.6 GlaxoSmithKline Recent Developments
9.3 Sanofi
9.3.1 Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Basic Information
9.3.2 Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Product Overview
9.3.3 Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Product Market Performance
9.3.4 Sanofi Diphtheria, Pertussis, and Tetanus Vaccine SWOT Analysis
9.3.5 Sanofi Business Overview
9.3.6 Sanofi Recent Developments
9.4 Lanzhou Institute of Biological
9.4.1 Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Basic Information
9.4.2 Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Product Overview
9.4.3 Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Product Market Performance
9.4.4 Lanzhou Institute of Biological Business Overview
9.4.5 Lanzhou Institute of Biological Recent Developments
9.5 Merck
9.5.1 Merck Diphtheria, Pertussis, and Tetanus Vaccine Basic Information
9.5.2 Merck Diphtheria, Pertussis, and Tetanus Vaccine Product Overview
9.5.3 Merck Diphtheria, Pertussis, and Tetanus Vaccine Product Market Performance
9.5.4 Merck Business Overview
9.5.5 Merck Recent Developments
9.6 Novartis
9.6.1 Novartis Diphtheria, Pertussis, and Tetanus Vaccine Basic Information
9.6.2 Novartis Diphtheria, Pertussis, and Tetanus Vaccine Product Overview
9.6.3 Novartis Diphtheria, Pertussis, and Tetanus Vaccine Product Market Performance
9.6.4 Novartis Business Overview
9.6.5 Novartis Recent Developments
9.7 AstraZeneca
9.7.1 AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Basic Information
9.7.2 AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Product Overview
9.7.3 AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Product Market Performance
9.7.4 AstraZeneca Business Overview
9.7.5 AstraZeneca Recent Developments
9.8 Emergent
9.8.1 Emergent Diphtheria, Pertussis, and Tetanus Vaccine Basic Information
9.8.2 Emergent Diphtheria, Pertussis, and Tetanus Vaccine Product Overview
9.8.3 Emergent Diphtheria, Pertussis, and Tetanus Vaccine Product Market Performance
9.8.4 Emergent Business Overview
9.8.5 Emergent Recent Developments
9.9 Astellas
9.9.1 Astellas Diphtheria, Pertussis, and Tetanus Vaccine Basic Information
9.9.2 Astellas Diphtheria, Pertussis, and Tetanus Vaccine Product Overview
9.9.3 Astellas Diphtheria, Pertussis, and Tetanus Vaccine Product Market Performance
9.9.4 Astellas Business Overview
9.9.5 Astellas Recent Developments
10 DIPHTHERIA, PERTUSSIS, AND TETANUS VACCINE MARKET FORECAST BY REGION
10.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size Forecast
10.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Diphtheria, Pertussis, and Tetanus Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Market Size Forecast by Region
10.2.4 South America Diphtheria, Pertussis, and Tetanus Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Diphtheria, Pertussis, and Tetanus Vaccine by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Diphtheria, Pertussis, and Tetanus Vaccine by Type (2025-2030)
11.1.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Diphtheria, Pertussis, and Tetanus Vaccine by Type (2025-2030)
11.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Forecast by Application (2025-2030)
11.2.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales (Kilotons) Forecast by Application
11.2.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Diphtheria, Pertussis, and Tetanus Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diphtheria, Pertussis, and Tetanus Vaccine as of 2022)
Table 10. Global Market Diphtheria, Pertussis, and Tetanus Vaccine Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Diphtheria, Pertussis, and Tetanus Vaccine Sales Sites and Area Served
Table 12. Manufacturers Diphtheria, Pertussis, and Tetanus Vaccine Product Type
Table 13. Global Diphtheria, Pertussis, and Tetanus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Diphtheria, Pertussis, and Tetanus Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Diphtheria, Pertussis, and Tetanus Vaccine Market Challenges
Table 22. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (Kilotons)
Table 23. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size by Type (M USD)
Table 24. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales (Kilotons) by Type (2019-2024)
Table 25. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Type (2019-2024)
Table 26. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size (M USD) by Type (2019-2024)
Table 27. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size Share by Type (2019-2024)
Table 28. Global Diphtheria, Pertussis, and Tetanus Vaccine Price (USD/Ton) by Type (2019-2024)
Table 29. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales (Kilotons) by Application
Table 30. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size by Application
Table 31. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Application (2019-2024)
Table 33. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2019-2024) & (M USD)
Table 34. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Share by Application (2019-2024)
Table 35. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Growth Rate by Application (2019-2024)
Table 36. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Region (2019-2024)
Table 38. North America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 43. Johnson and Johnson Diphtheria, Pertussis, and Tetanus Vaccine Basic Information
Table 44. Johnson and Johnson Diphtheria, Pertussis, and Tetanus Vaccine Product Overview
Table 45. Johnson and Johnson Diphtheria, Pertussis, and Tetanus Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Johnson and Johnson Business Overview
Table 47. Johnson and Johnson Diphtheria, Pertussis, and Tetanus Vaccine SWOT Analysis
Table 48. Johnson and Johnson Recent Developments
Table 49. GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Basic Information
Table 50. GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Product Overview
Table 51. GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. GlaxoSmithKline Business Overview
Table 53. GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine SWOT Analysis
Table 54. GlaxoSmithKline Recent Developments
Table 55. Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Basic Information
Table 56. Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Product Overview
Table 57. Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Sanofi Diphtheria, Pertussis, and Tetanus Vaccine SWOT Analysis
Table 59. Sanofi Business Overview
Table 60. Sanofi Recent Developments
Table 61. Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Basic Information
Table 62. Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Product Overview
Table 63. Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Lanzhou Institute of Biological Business Overview
Table 65. Lanzhou Institute of Biological Recent Developments
Table 66. Merck Diphtheria, Pertussis, and Tetanus Vaccine Basic Information
Table 67. Merck Diphtheria, Pertussis, and Tetanus Vaccine Product Overview
Table 68. Merck Diphtheria, Pertussis, and Tetanus Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Merck Business Overview
Table 70. Merck Recent Developments
Table 71. Novartis Diphtheria, Pertussis, and Tetanus Vaccine Basic Information
Table 72. Novartis Diphtheria, Pertussis, and Tetanus Vaccine Product Overview
Table 73. Novartis Diphtheria, Pertussis, and Tetanus Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Novartis Business Overview
Table 75. Novartis Recent Developments
Table 76. AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Basic Information
Table 77. AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Product Overview
Table 78. AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. AstraZeneca Business Overview
Table 80. AstraZeneca Recent Developments
Table 81. Emergent Diphtheria, Pertussis, and Tetanus Vaccine Basic Information
Table 82. Emergent Diphtheria, Pertussis, and Tetanus Vaccine Product Overview
Table 83. Emergent Diphtheria, Pertussis, and Tetanus Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Emergent Business Overview
Table 85. Emergent Recent Developments
Table 86. Astellas Diphtheria, Pertussis, and Tetanus Vaccine Basic Information
Table 87. Astellas Diphtheria, Pertussis, and Tetanus Vaccine Product Overview
Table 88. Astellas Diphtheria, Pertussis, and Tetanus Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Astellas Business Overview
Table 90. Astellas Recent Developments
Table 91. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 92. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 93. North America Diphtheria, Pertussis, and Tetanus Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 94. North America Diphtheria, Pertussis, and Tetanus Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 95. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 96. Europe Diphtheria, Pertussis, and Tetanus Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 97. Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 98. Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 99. South America Diphtheria, Pertussis, and Tetanus Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 100. South America Diphtheria, Pertussis, and Tetanus Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 101. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Consumption Forecast by Country (2025-2030) & (Units)
Table 102. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 103. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Forecast by Type (2025-2030) & (Kilotons)
Table 104. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size Forecast by Type (2025-2030) & (M USD)
Table 105. Global Diphtheria, Pertussis, and Tetanus Vaccine Price Forecast by Type (2025-2030) & (USD/Ton)
Table 106. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales (Kilotons) Forecast by Application (2025-2030)
Table 107. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Diphtheria, Pertussis, and Tetanus Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diphtheria, Pertussis, and Tetanus Vaccine as of 2022)
Table 10. Global Market Diphtheria, Pertussis, and Tetanus Vaccine Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Diphtheria, Pertussis, and Tetanus Vaccine Sales Sites and Area Served
Table 12. Manufacturers Diphtheria, Pertussis, and Tetanus Vaccine Product Type
Table 13. Global Diphtheria, Pertussis, and Tetanus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Diphtheria, Pertussis, and Tetanus Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Diphtheria, Pertussis, and Tetanus Vaccine Market Challenges
Table 22. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (Kilotons)
Table 23. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size by Type (M USD)
Table 24. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales (Kilotons) by Type (2019-2024)
Table 25. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Type (2019-2024)
Table 26. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size (M USD) by Type (2019-2024)
Table 27. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size Share by Type (2019-2024)
Table 28. Global Diphtheria, Pertussis, and Tetanus Vaccine Price (USD/Ton) by Type (2019-2024)
Table 29. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales (Kilotons) by Application
Table 30. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size by Application
Table 31. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Application (2019-2024)
Table 33. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2019-2024) & (M USD)
Table 34. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Share by Application (2019-2024)
Table 35. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Growth Rate by Application (2019-2024)
Table 36. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Region (2019-2024)
Table 38. North America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 43. Johnson and Johnson Diphtheria, Pertussis, and Tetanus Vaccine Basic Information
Table 44. Johnson and Johnson Diphtheria, Pertussis, and Tetanus Vaccine Product Overview
Table 45. Johnson and Johnson Diphtheria, Pertussis, and Tetanus Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Johnson and Johnson Business Overview
Table 47. Johnson and Johnson Diphtheria, Pertussis, and Tetanus Vaccine SWOT Analysis
Table 48. Johnson and Johnson Recent Developments
Table 49. GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Basic Information
Table 50. GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Product Overview
Table 51. GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. GlaxoSmithKline Business Overview
Table 53. GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine SWOT Analysis
Table 54. GlaxoSmithKline Recent Developments
Table 55. Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Basic Information
Table 56. Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Product Overview
Table 57. Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Sanofi Diphtheria, Pertussis, and Tetanus Vaccine SWOT Analysis
Table 59. Sanofi Business Overview
Table 60. Sanofi Recent Developments
Table 61. Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Basic Information
Table 62. Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Product Overview
Table 63. Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Lanzhou Institute of Biological Business Overview
Table 65. Lanzhou Institute of Biological Recent Developments
Table 66. Merck Diphtheria, Pertussis, and Tetanus Vaccine Basic Information
Table 67. Merck Diphtheria, Pertussis, and Tetanus Vaccine Product Overview
Table 68. Merck Diphtheria, Pertussis, and Tetanus Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Merck Business Overview
Table 70. Merck Recent Developments
Table 71. Novartis Diphtheria, Pertussis, and Tetanus Vaccine Basic Information
Table 72. Novartis Diphtheria, Pertussis, and Tetanus Vaccine Product Overview
Table 73. Novartis Diphtheria, Pertussis, and Tetanus Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Novartis Business Overview
Table 75. Novartis Recent Developments
Table 76. AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Basic Information
Table 77. AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Product Overview
Table 78. AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. AstraZeneca Business Overview
Table 80. AstraZeneca Recent Developments
Table 81. Emergent Diphtheria, Pertussis, and Tetanus Vaccine Basic Information
Table 82. Emergent Diphtheria, Pertussis, and Tetanus Vaccine Product Overview
Table 83. Emergent Diphtheria, Pertussis, and Tetanus Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Emergent Business Overview
Table 85. Emergent Recent Developments
Table 86. Astellas Diphtheria, Pertussis, and Tetanus Vaccine Basic Information
Table 87. Astellas Diphtheria, Pertussis, and Tetanus Vaccine Product Overview
Table 88. Astellas Diphtheria, Pertussis, and Tetanus Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Astellas Business Overview
Table 90. Astellas Recent Developments
Table 91. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 92. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 93. North America Diphtheria, Pertussis, and Tetanus Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 94. North America Diphtheria, Pertussis, and Tetanus Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 95. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 96. Europe Diphtheria, Pertussis, and Tetanus Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 97. Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 98. Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 99. South America Diphtheria, Pertussis, and Tetanus Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 100. South America Diphtheria, Pertussis, and Tetanus Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 101. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Consumption Forecast by Country (2025-2030) & (Units)
Table 102. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 103. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Forecast by Type (2025-2030) & (Kilotons)
Table 104. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size Forecast by Type (2025-2030) & (M USD)
Table 105. Global Diphtheria, Pertussis, and Tetanus Vaccine Price Forecast by Type (2025-2030) & (USD/Ton)
Table 106. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales (Kilotons) Forecast by Application (2025-2030)
Table 107. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Diphtheria, Pertussis, and Tetanus Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size (M USD), 2019-2030
Figure 5. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size (M USD) (2019-2030)
Figure 6. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Diphtheria, Pertussis, and Tetanus Vaccine Market Size by Country (M USD)
Figure 11. Diphtheria, Pertussis, and Tetanus Vaccine Sales Share by Manufacturers in 2023
Figure 12. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Share by Manufacturers in 2023
Figure 13. Diphtheria, Pertussis, and Tetanus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Diphtheria, Pertussis, and Tetanus Vaccine Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Diphtheria, Pertussis, and Tetanus Vaccine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Share by Type
Figure 18. Sales Market Share of Diphtheria, Pertussis, and Tetanus Vaccine by Type (2019-2024)
Figure 19. Sales Market Share of Diphtheria, Pertussis, and Tetanus Vaccine by Type in 2023
Figure 20. Market Size Share of Diphtheria, Pertussis, and Tetanus Vaccine by Type (2019-2024)
Figure 21. Market Size Market Share of Diphtheria, Pertussis, and Tetanus Vaccine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Share by Application
Figure 24. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Application (2019-2024)
Figure 25. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Application in 2023
Figure 26. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Share by Application (2019-2024)
Figure 27. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Share by Application in 2023
Figure 28. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Growth Rate by Application (2019-2024)
Figure 29. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Region (2019-2024)
Figure 30. North America Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Country in 2023
Figure 32. U.S. Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Diphtheria, Pertussis, and Tetanus Vaccine Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Diphtheria, Pertussis, and Tetanus Vaccine Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Country in 2023
Figure 37. Germany Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Region in 2023
Figure 44. China Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (Kilotons)
Figure 50. South America Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Country in 2023
Figure 51. Brazil Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Share Forecast by Type (2025-2030)
Figure 65. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Forecast by Application (2025-2030)
Figure 66. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Diphtheria, Pertussis, and Tetanus Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size (M USD), 2019-2030
Figure 5. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size (M USD) (2019-2030)
Figure 6. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Diphtheria, Pertussis, and Tetanus Vaccine Market Size by Country (M USD)
Figure 11. Diphtheria, Pertussis, and Tetanus Vaccine Sales Share by Manufacturers in 2023
Figure 12. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Share by Manufacturers in 2023
Figure 13. Diphtheria, Pertussis, and Tetanus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Diphtheria, Pertussis, and Tetanus Vaccine Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Diphtheria, Pertussis, and Tetanus Vaccine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Share by Type
Figure 18. Sales Market Share of Diphtheria, Pertussis, and Tetanus Vaccine by Type (2019-2024)
Figure 19. Sales Market Share of Diphtheria, Pertussis, and Tetanus Vaccine by Type in 2023
Figure 20. Market Size Share of Diphtheria, Pertussis, and Tetanus Vaccine by Type (2019-2024)
Figure 21. Market Size Market Share of Diphtheria, Pertussis, and Tetanus Vaccine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Share by Application
Figure 24. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Application (2019-2024)
Figure 25. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Application in 2023
Figure 26. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Share by Application (2019-2024)
Figure 27. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Share by Application in 2023
Figure 28. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Growth Rate by Application (2019-2024)
Figure 29. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Region (2019-2024)
Figure 30. North America Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Country in 2023
Figure 32. U.S. Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Diphtheria, Pertussis, and Tetanus Vaccine Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Diphtheria, Pertussis, and Tetanus Vaccine Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Country in 2023
Figure 37. Germany Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Region in 2023
Figure 44. China Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (Kilotons)
Figure 50. South America Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Country in 2023
Figure 51. Brazil Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Share Forecast by Type (2025-2030)
Figure 65. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Forecast by Application (2025-2030)
Figure 66. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Share Forecast by Application (2025-2030)